E-mail: tomas.pika@fnol.cz
Odborné práce publikované na Linkos.cz
Přehled odborných textů publikovaných autorem na portálu Linkos.cz. Jsou zde uvedeny knihy a brožury, články v Klinické onkologii, tuzemská abstrakta z databáze abstrakt a další texty. Rejstřík není v žádném případě úplným autorským rejstříkem, protože jsou zde uvedeny pouze texty zveřejněné na portálu Linkos.cz.
Publikovaná abstrakta
- 18F-FDG PET/CT AND 99MTC-MIBI SCINTIGRAPHY LOCALIZE ACTIVE MYELOMA LESIONS AND CORRELATE WITH INCREASED SERUM LEVELS OF THYMIDINE KINASE DETECTED BY NOVEL METHOD DIVITUM™
- ALTERNATION OF SELECTED BIOLOGICAL PARAMETERS AFTER AUTOLOGOUS TRANSPLANTATION IN MULTIPLE MYELOMA PATIENTS
- Amyloidóza v morfologickém a klinickém obraze
- Assessment of the Parameters of Myeloma Bone Disease Signaling to the Extent of Skeletal Involvement, Bone Mineral Turnover and Activity of Multiple Myeloma
- Bortezomib (Velcade) in the Treatment of Relapsed or Refractory Multiple Myeloma: Analysis of Safety and Efficacy of Bortezomib From Registry of Monoclonal Gammopathy of Czech Myeloma Group
- CARDIAC IMPAIRMENT BY AL-AMYLOIDOSIS
- Carfilzomib and dexamethasone (Kd) vs bortezomib and dexamethasone (Vd) in patients (pts) with relapsed multiple myeloma (RMM): Results from the phase III study ENDEAVOR.
- CARFILZOMIB AND DEXAMETHASONE IMPROVES PROGRESSIONFREE SURVIVAL AND RESPONSE RATES VS BORTEZOMIB AND DEXAMETHASONE IN PATIENTS (PTS) WITH RELAPSED MULTIPLE MYELOMA (RMM): THE PHASE 3 STUDY ENDEAVOR
- Carfilzomib and Dexamethasone Vs Bortezomib and Dexamethasone in Patients with Relapsed Multiple Myeloma: Results of the Phase 3 Study Endeavor (NCT01568866) According to Age Subgroup
- Combined Measurement of Plasma Cell Proliferation and Apoptosis in Multiple Myeloma
- COMPARISON OF PROGNOSTIC SIGNIFICANCE OF SELECTED BIOLOGICAL PARAMETERS IN MULTIPLE MYELOMA IN THE CASE OF CONVENTIONAL CHEMOTHERAPY OR HIGH DOSE THERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION
- COMPARISON OF SERUM LEVELS OF BIOLOGICAL PARAMETERS IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE AND MULTIPLE MYELOMA
- CYTOKINETIC STUDIES IN MULTIPLE MYELOMA: PROLIFERATION AND APOPTOSIS IN EARLY RESPONDERS
- DELETION OF 14Q INVOLVING IGH GENE IN PATIENTS WITH MULTIPLE MYELOMA
- Efficacy and Safety of Carfilzomib and Dexamethasone Vs Bortezomib and Dexamethasone in Patients with Relapsed Multiple Myeloma Based on Cytogenetic Risk Status: Subgroup Analysis from the Phase 3 Study Endeavor (NCT01568866)
- EVALUATION OF THE RELATION BETWEEN ANGIOGENIC CYTOKINES, SELECTED BIOLOGICAL PARAMETERS AND PROGNOSTIC FACTORS IN MULTIPLE MYELOMA
- Hevylite reagents - imunohistochemická studie
- IDENTIFICATION OF PROGNOSTIC FACTORS FOR MALIGNANT TRANSFORMATION IN PERSONS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE OBSERVED IN THE CZECH REPUBLIC
- IMMUNOPARESIS CORRELATES WITH MGUS RISK - APPLICATION OF POLYCLONAL IMMUNOGLOBULIN AND HEAVY/LIGHT CHAIN LEVELS ASSESSMENT
- Impact of Prior Treatment on Patients with Relapsed Multiple Myeloma Treated with Carfilzomib and Dexamethasone Vs Bortezomib and Dexamethasone in a Subgroup Analysis of the Phase 3 Endeavor Study (NCT01568866)
- Multiple myeloma and bone marrow microenvironment - immunohistochemical study
- NONSECRETORY MYELOMA – SECRETORY POTENTIAL & CYTOGENETIC CHANGES
- PARTIAL ´LIGHT-CHAIN ESCAPE´ PHENOMENON & CYTOGENETIC CHANGES – TWO CASE STUDIES
- PILOT ASSESSMENT OF PROXIMITY EXTENTION IMMUNOASSAY IN PATIENTS WITH MONOCLONAL GAMMOPATHIES: PARALLEL EVALUATION OF 92 CANCER-RELATED PARAMETERS IN BONE MARROW AND IN SERA
- PLASMA CELL PROPIDIUM IODIDE (PC-PI/CD138) AND ANNEXIN V (PC-AI/CD138) INDICES IN MULTIPLE MYELOMA AND MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE – EARLY PREDICTORS OF TRANSFORMATION?
- Prognostický význam 99mTc-MIBI scintigrafie u mnohočetného myelomu
- RELATIONSHIP OF SERUM FREE LIGHT CHAIN LEVELS AND SELECTED BIOLOGICAL PARAMETERS IN PATIENTS WITH MULTIPLE MYELOMA
- RELATIONSHIP OF SERUM FREE LIGHT CHAIN LEVELS TO DEGREE OF MULTIPLE MYELOMA PROGESSION
- SERUM LEVELS OF DICKKOPF-1 PREDICT PROGRESSION FREE SURVIVAL IN MULTIPLE MYELOMA PATIENTS TREATED WITH AUTOLOGOUS STEM CELL TRANSPLANTAT BUT ITS PROGNOSTIC VALUE IS OVERCOME BY THE USE OF NOVEL DRUGS
- SERUM LEVELS OF SELECTED PARAMETERS OF BONE MICROENVIRONMENT PREDICT OVERALL SURVIVAL IN MULTIPLE MYELOMA PATIENTS REGARDLESS OF TREATMENT REGIMEN USED
- Subcutaneous and Intravenous Bortezomib in Multiple Myeloma Patients Has Similar Response Rates and Toxicity Profile with No Difference in the Incidence of Peripheral Neuropathy: Report of the Czech Myeloma Group
- Subtyping of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics analysis
- THE COMPARISON OF SERUM LEVELS OF SELECTED BIOMARKERS AND CYTOGENETIC CHANGES IN MULTIPLE MYELOMA
- THE DYNAMICS OF SERUM CROSSLAPS AND SCLEROSTIN LEVELS CORRELATES WITH TREATMENT RESPONSE IN MULTIPLE MYELOMA PATIENTS WITH THE PRESENCE OF MYELOMA BONE DISEASE
- TRANSFORMATION OF MGUS INTO LIGHT CHAIN DEPOSITION DISEASE WITH A FAVORABLE RESPONSE TO BORTEZOMIB TREATMENT
- TRANSLOCATION T(14;16): FREQUENCY AND SIGNIFICANCE IN PATIENTS WITH MULTIPLE MYELOMA
- Zhodnocení přínosu biologické terapie pro prognózu nemocných s mnohočetným myelomem - zkušenosti jednoho pracoviště
- Zhodnocení přínosu biologické terapie pro prognózu nemocných s mnohočetným myelomem - zkušenosti jednoho pracoviště
- Změny sérových hladin vybraných biologických ukazatelů po autologní transplantaci u nemocných s mnohočetným myelomem
Články v Klinické onkologii
- Analýza sérových hladin vybraných biologických ukazatelů u monoklonální gamapatie nejistého významu a mnohočetného myelomu
- Dosažení kompletní hematologické remise je zásadní pro prodloužení přežití nemocných s AL amyloidózou a srdečním postižením
- Vyšetření párů těžkých/ lehkých řetězců imunoglobulinu (Hevylite™ assay) – přínos pro stratifikaci mnohočetného myelomu?
